Details of the Drug Reposition

General Information of This Drug (ID: DMYD37G)

• Drug Name: CV8102 (DMYD37G)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Squamous cell carcinoma	DISQVIFL	2B60-2D01	Phase 1	[1]
Melanoma	DIS1RRCY	2C30	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT03291002) Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC. U.S. National Institutes of Health.